Gluconic Acid

Identification

Name
Gluconic Acid
Accession Number
DB13180  (DB09408)
Type
Small Molecule
Groups
Approved, Investigational
Description

Commonly found in salts with sodium and calcium. Gluconic acid or gluconate is used to maintain the cation-anion balance on electrolyte solutions.

Structure
Thumb
Synonyms
  • D-Gluconic Acid
  • Dextronic acid
  • Maltonic acid
External IDs
E-574 / INS no.574 / INS-574 / NSC-77381 / Pentahydroxycaproic acid
Product Ingredients
IngredientUNIICASInChI Key
Sodium gluconateR6Q3791S76527-07-1UPMFZISCCZSDND-JJKGCWMISA-M
Active Moieties
NameKindUNIICASInChI Key
Sodium cationionicLYR4M0NH3717341-25-2FKNQFGJONOIPTF-UHFFFAOYSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Hyperlyte (multi-electrolyte Concentrate)Sodium gluconate (1.09 g) + Calcium acetate (440 mg) + Magnesium acetate (860 mg) + Potassium Chloride (2.46 g) + Potassium acetate (690 mg) + Sodium acetate (2.72 g)LiquidIntravenousB. Braun Medical Inc.1998-09-04Not applicableCanada
Isolyte SSodium gluconate (0.5 g/100mL) + Magnesium chloride hexahydrate (0.03 g/100mL) + Potassium Chloride (0.037 g/100mL) + Sodium Chloride (0.53 g/100mL) + Sodium acetate trihydrate (0.37 g/100mL)Injection, solutionIntravenousB. Braun Medical Inc.1989-09-29Not applicableUs
Isolyte S (multi-electrolyte Injection)Sodium gluconate (500 mg) + Magnesium chloride (30 mg) + Potassium Chloride (37 mg) + Sodium Chloride (530 mg) + Sodium acetate (370 mg)SolutionIntravenousB. Braun Medical Inc.1992-12-31Not applicableCanada
Isolyte S in DextroseSodium gluconate (0.5 g/100mL) + Dextrose, unspecified form (5 g/100mL) + Magnesium chloride hexahydrate (0.03 g/100mL) + Potassium Chloride (0.037 g/100mL) + Sodium Chloride (0.53 g/100mL) + Sodium acetate trihydrate (0.37 g/100mL)Injection, solutionIntravenousB. Braun Medical Inc.1993-08-09Not applicableUs
Isolyte S pH 7.4Sodium gluconate (0.5 g/100mL) + Magnesium chloride hexahydrate (0.03 g/100mL) + Monopotassium phosphate (0.00082 g/100mL) + Potassium Chloride (0.037 g/100mL) + Sodium Chloride (0.53 g/100mL) + Sodium acetate trihydrate (0.37 g/100mL) + Sodium phosphate, dibasic, unspecified form (0.012 g/100mL)Injection, solutionIntravenousB. Braun Medical Inc.1989-09-29Not applicableUs
Isolyte S Ph 7.4 (multi-electrolyte Injection)Sodium gluconate (500 mg) + Magnesium chloride (30 mg) + Monopotassium phosphate (820 mcg) + Potassium Chloride (37 mg) + Sodium Chloride (530 mg) + Sodium acetate (370 mg) + Sodium phosphate, dibasic (12 mg)SolutionIntravenousB. Braun Medical Inc.1996-09-10Not applicableCanada
Isolyte S With 5% Dextrose InjSodium gluconate (500 mg) + Dextrose, unspecified form (5 g) + Magnesium chloride (30 mg) + Potassium Chloride (37 mg) + Sodium Chloride (530 mg) + Sodium acetate (370 mg)SolutionIntravenousB. Braun Medical Inc.1996-09-10Not applicableCanada
IsoplateSodium gluconate (0.5 g/100mL) + Magnesium chloride hexahydrate (0.03 g/100mL) + Monopotassium phosphate (0.00082 g/100mL) + Potassium Chloride (0.037 g/100mL) + Sodium Chloride (0.53 g/100mL) + Sodium acetate trihydrate (0.37 g/100mL) + Sodium phosphate, dibasic, unspecified form (0.008 g/100mL)SolutionIntravenousTerumo Bct2013-03-05Not applicableUs
IsoplateSodium gluconate (0.5 g/100mL) + Magnesium chloride hexahydrate (0.03 g/100mL) + Monopotassium phosphate (0.00082 g/100mL) + Potassium Chloride (0.037 g/100mL) + Sodium Chloride (0.53 g/100mL) + Sodium acetate trihydrate (0.37 g/100mL) + Sodium phosphate, dibasic, unspecified form (0.012 g/100mL)SolutionIntravenousB. Braun Medical Inc.2013-03-052013-04-19Us
LypholyteSodium gluconate (1.1 g) + Calcium acetate (440 mg) + Magnesium acetate (860 mg) + Potassium Chloride (2.5 g) + Potassium acetate (690 mg) + Sodium acetate (2.7 g)SolutionIntravenousPartners Health Care, Inc.1996-08-142008-01-10Canada
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
NutrilyteSodium gluconate (55 mg/1mL) + Calcium acetate (22 mg/1mL) + Magnesium acetate (43 mg/1mL) + Potassium Chloride (125 mg/1mL) + Potassium acetate (34.5 mg/1mL) + Sodium acetate trihydrate (135 mg/1mL)Injection, solution, concentrateIntravenousAmerican Regent1990-09-302013-05-08Us
Categories
UNII
R4R8J0Q44B
CAS number
526-95-4
Weight
Average: 196.1553
Monoisotopic: 196.058302738
Chemical Formula
C6H12O7
InChI Key
RGHNJXZEOKUKBD-SQOUGZDYSA-N
InChI
InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3-,4+,5-/m1/s1
IUPAC Name
(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O

Pharmacology

Indication

For use as part of electrolyte supplementation in total parenteral nutrition [Label].

Associated Therapies
Pharmacodynamics

Used as part of electrolyte salts to maintain cation-anion balance in solutions.

Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Gluconic Acid.
AgmatineThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Agmatine.
AlfentanilThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Alfentanil.
AlphacetylmethadolThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Alphacetylmethadol.
AlphaprodineThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Alphaprodine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Gluconic Acid.
AmiodaroneThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Amiodarone.
AmlodipineThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Amlodipine.
AranidipineThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Aranidipine.
AzelnidipineThe therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Azelnidipine.
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB0000625
KEGG Compound
C00257
PubChem Compound
10690
PubChem Substance
347829282
ChemSpider
10240
ChEBI
33198
ChEMBL
CHEMBL464345
PharmGKB
PA449770
HET
GCO
Wikipedia
Gluconic_acid
PDB Entries
1bgg / 1xlf / 3o03 / 3oy8 / 3qke / 3t6c / 3twb / 4k2s / 4zlg

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0CompletedDiagnosticHuman Immunodeficiency Virus (HIV) Infections1
1, 2Not Yet RecruitingTreatmentAcute Respiratory Distress Syndrome (ARDS)1
2CompletedPreventionAcute Kidney Injury (AKI)1
2CompletedTreatmentNeoplasms, Brain1
2CompletedTreatmentRespiratory Distress Syndrome, Adult1
2RecruitingTreatmentAnterior Wall Myocardial Infarction1
3Enrolling by InvitationTreatmentAnaesthesia therapy1
3RecruitingTreatmentAcidosis, Metabolic / Critical Illness1
4RecruitingTreatmentHypovolaemia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidIntravenous
Injection, solution, concentrateIntravenous
IrrigantIrrigation
Injection, solutionIntravenous
SolutionIntravenous
Powder, for solutionIrrigation; Topical
Prices
Not Available
Patents
Not Available

Properties

State
Liquid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility159.0 mg/mLALOGPS
logP-2.6ALOGPS
logP-3.4ChemAxon
logS-0.09ALOGPS
pKa (Strongest Acidic)3.39ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area138.45 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity38.27 m3·mol-1ChemAxon
Polarizability17.15 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0002-0932000000-202af87cea2d1f7184ab
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-005a-0920000000-2308d9356bc5bb01420e
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-014j-0950000000-61ab7adf15e353df4ba2
GC-MS Spectrum - GC-MS (6 TMS)GC-MSsplash10-0le9-1964000000-5eb7d6777170e1ad5fa0
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-0932000000-202af87cea2d1f7184ab
GC-MS Spectrum - GC-MSGC-MSsplash10-0le9-1964000000-5eb7d6777170e1ad5fa0
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-0931000000-b07fcc4ac1e6701d32c8
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0fr2-0930000000-181f7b697b591cf8080b
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-06vj-1900000000-78e4a5d92be678c068e4
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-03ds-5900000000-f5d8284baa473ce9d77f
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-014i-9500000000-7c5b20eef98d0e3d6cbb
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, NegativeLC-MS/MSsplash10-0002-0900000000-b2632ca9154cc5e44438
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, NegativeLC-MS/MSsplash10-002b-5900000000-4a3066f9dfd6653682fb
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, NegativeLC-MS/MSsplash10-004i-9000000000-50f63dfd017a8380a47c
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, NegativeLC-MS/MSsplash10-056r-9000000000-91ccf7c8949c1c9d852a
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, NegativeLC-MS/MSsplash10-0a6r-9000000000-6e40f1cebd8b460016b3
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0002-0900000000-b2632ca9154cc5e44438
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-002b-5900000000-cf9b480ac397acfebc71
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-004i-9000000000-eca61f6a9c0f1d06e84d
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-056r-9000000000-91ccf7c8949c1c9d852a
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0a6r-9000000000-6e40f1cebd8b460016b3
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
[1H,1H] 2D NMR Spectrum2D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable

Taxonomy

Description
This compound belongs to the class of organic compounds known as sugar acids and derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbohydrates and carbohydrate conjugates
Direct Parent
Sugar acids and derivatives
Alternative Parents
Medium-chain hydroxy acids and derivatives / Medium-chain fatty acids / Hydroxy fatty acids / Beta hydroxy acids and derivatives / Monosaccharides / Alpha hydroxy acids and derivatives / Secondary alcohols / Polyols / Monocarboxylic acids and derivatives / Carboxylic acids
show 4 more
Substituents
Gluconic_acid / Medium-chain hydroxy acid / Medium-chain fatty acid / Beta-hydroxy acid / Hydroxy fatty acid / Alpha-hydroxy acid / Fatty acyl / Fatty acid / Hydroxy acid / Monosaccharide
show 11 more
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
gluconic acid (CHEBI:33198) / Uronic acids (C00257)

Drug created on June 08, 2017 20:30 / Updated on November 02, 2018 09:10